Protective Factors Modulate the Risk of Beta Amyloid in Alzheimer’s Disease
Aim. To identify the factors protecting Abeta-positive subjects with normal cognition (NC) or mild cognitive impairment (MCI) from conversion to Alzheimer’s disease (AD). Methods. Subjects with MCI in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database, with baseline data for neuropsycho...
Saved in:
| Main Authors: | Bin Zhou, Kenichiro Tanabe, Shinsuke Kojima, Satoshi Teramukai, Masanori Fukushima, The Alzheimer’s Disease Neuroimaging Initiative |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Behavioural Neurology |
| Online Access: | http://dx.doi.org/10.1155/2020/7029642 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serotonin enhances neurogenesis biomarkers, hippocampal volumes, and cognitive functions in Alzheimer’s disease
by: Ali Azargoonjahromi, et al.
Published: (2024-12-01) -
CSF Amyloid-β42 associates with neuropsychiatric and cognitive outcomes via cerebral glucose metabolism
by: Ali Azargoonjahromi, et al.
Published: (2025-07-01) -
Detection of Alzheimer’s Disease Using Hybrid Meta-ROI of MRI Structural Images
by: Xiaoming Zheng, et al.
Published: (2024-10-01) -
Integrative network analysis reveals novel moderators of Aβ-Tau interaction in Alzheimer's disease
by: Akihiro Kitani, et al.
Published: (2025-04-01) -
Early diagnosis of Alzheimer’s disease and mild cognitive impairment using MRI analysis and machine learning algorithms
by: Helia Givian, et al.
Published: (2024-12-01)